WESTLAKE VILLAGE, Calif. - 美国食品和药物管理局（FDA）已接受Arcutis Biotherapeutics, Inc.（NASDAQ:ARQT）提交的ZORYVE（roflumilast）泡沫剂补充新药申请（sNDA），该药物用于治疗头皮和身体银屑病。FDA已将处方药用户费法案（PDUFA）目标行动日期定为2025年5月22日。 Arcutis是一家处于商业化阶段的生 ...

According to the recent study published in the Journal of American Medical Association, a new topical treatment for atopic dermatitis (AD) has been shown as a safe, effective, and ...

在其他近期新闻中，Arcutis Biotherapeutics报告2024年第二季度业绩强劲，净收入达到30.9百万美元，较第一季度净产品收入增长43%。这一增长主要由其皮肤病产品（包括Zoryve乳膏和泡沫）的处方量显著增长推动。Mizuho Securities和TD ...

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...

Skin diseases are pathologic conditions that affect the body's surfaces (also called the integument), including skin, hair, nails and associated glands. They can involve all layers of the skin and ...

Formation of keratinized scales Scales are formed by folds of the integument. Raised and depressed areas appear in the integument. Each bump consists of epidermis with the dermis underneath it and is ...

(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ...

Experts at the Skin of Color Update today in New York City highlighted recent FDA-approved dermatological treatments and ...

More information: George Poinar, Ectoparasitic nematodes developing in the integument of a Baltic amber pseudoscorpion, Historical Biology (2024). DOI: 10.1080/08912963.2024.2341848 ...

Consequently, this strategy can be useful only to small ectotherms with a highly-permeable integument and profound desiccation tolerance. Excessively deep or prolonged chilling can result in ...

To stabilise themselves, they’d possibly have thrown their arms out on the side, like a sky diver. This would make them descend more slowly. Next, the integument, the feathers and skin, could have ...

Roflumilast cream 0.15% was well tolerated and significantly improved symptoms in adults and children with mild to moderate atopic dermatitis (AD) in two phase 3 trials. The two phase 3 randomized ...